• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日间护理项目治疗银屑病的疗效。

Efficacy of a day-care program in the treatment of psoriasis.

作者信息

Zhang Junling, Adam David N, Stebbing Elaine, Gerbrandt Judith, Lui Harvey, Shapiro Jerry, Zhou Youwen

机构信息

Psoriasis and Phototherapy Clinic, Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC.

出版信息

J Cutan Med Surg. 2008 Sep-Oct;12(5):211-6. doi: 10.2310/7750.2008.07069.

DOI:10.2310/7750.2008.07069
PMID:18845089
Abstract

BACKGROUND

Few data exist documenting the effectiveness of psoriasis day-care treatment programs (PDTPs) using standardized efficacy measurements.

OBJECTIVES

We sought to analyze the efficacy of a PDTP using the Psoriasis Area and Severity Index (PASI).

METHODS

A retrospective review was performed on 132 patients treated at our PDTP. Sufficient data existed to permit PASI analysis using a simplified method for a representative subgroup of 64 patients, who formed the study population. Patients received phototherapy and topical treatments over 2 weeks. The outcome measures included a baseline and day 11 PASI, a physician global assessment (PGA), and adverse events reported by the patients.

RESULTS

Mean baseline PASI was 13.6 (N = 64), with a 59.6% reduction by day 11. A PASI reduction of > or = 50% was seen in 75% of patients, with 30% of patients achieving > or = 75% reduction of PASI. Day 11 PGA demonstrated a 69.9% improvement.

CONCLUSION

With a reduction in PASI of 59.6% at 11 days, our PDTP, with phototherapy and topical agents, seems to be a rapid and effective therapy for psoriasis.

摘要

背景

使用标准化疗效测量方法记录银屑病日间护理治疗项目(PDTPs)有效性的数据很少。

目的

我们试图使用银屑病面积和严重程度指数(PASI)分析一个PDTP的疗效。

方法

对在我们的PDTP接受治疗的132例患者进行回顾性分析。有足够的数据允许对64例患者的代表性亚组使用简化方法进行PASI分析,这些患者构成了研究人群。患者在2周内接受光疗和局部治疗。结局指标包括基线和第11天的PASI、医生整体评估(PGA)以及患者报告的不良事件。

结果

平均基线PASI为13.6(N = 64),到第11天时降低了59.6%。75%的患者PASI降低≥50%,30%的患者PASI降低≥75%。第11天的PGA显示改善了69.9%。

结论

我们的PDTP采用光疗和局部用药,在11天时PASI降低了59.6%,似乎是一种治疗银屑病的快速有效疗法。

相似文献

1
Efficacy of a day-care program in the treatment of psoriasis.日间护理项目治疗银屑病的疗效。
J Cutan Med Surg. 2008 Sep-Oct;12(5):211-6. doi: 10.2310/7750.2008.07069.
2
Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.一种外观可接受的煤焦油溶液治疗中度斑块状银屑病的疗效和耐受性:与卡泊三醇乳膏(卡泊三醇)的对照比较。
Am J Clin Dermatol. 2010;11(4):275-83. doi: 10.2165/11530380-000000000-00000.
3
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years.乌司奴单抗治疗中重度斑块状银屑病患者的长期疗效:PHOENIX 1 试验长达 3 年的结果。
Br J Dermatol. 2012 Apr;166(4):861-72. doi: 10.1111/j.1365-2133.2012.10901.x.
4
Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.补骨脂素加紫外线 A 疗法与生物制剂治疗中重度慢性斑块状银屑病的疗效比较:患者登记处的回顾性数据分析。
Br J Dermatol. 2011 Sep;165(3):640-5. doi: 10.1111/j.1365-2133.2011.10396.x. Epub 2011 Jul 11.
5
Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.寻常型银屑病患者经外用、NB-UVB 和 PUVA 治疗后缓解期长短的主要决定因素:一项随访研究。
Am J Clin Dermatol. 2013 Feb;14(1):49-53. doi: 10.1007/s40257-012-0002-8.
6
Open-label, single-center, safety dose escalation trial of alefacept for the treatment of moderate to severe chronic plaque psoriasis.阿法赛特治疗中度至重度慢性斑块状银屑病的开放标签、单中心、安全剂量递增试验。
J Cutan Med Surg. 2007 Jul-Aug;11(4):132-6. doi: 10.2310/7750.2007.00025.
7
A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.一项评估在中重度斑块状银屑病患者中添加局部治疗药物联合依那西普的疗效和安全性的随机研究。
J Am Acad Dermatol. 2013 Sep;69(3):385-92. doi: 10.1016/j.jaad.2013.03.031. Epub 2013 May 1.
8
A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris.卡泊三醇乳膏与补骨脂素紫外线A光化学疗法(PUVA)联合治疗可降低紫外线A(UVA)剂量,并改善寻常型银屑病的疗效。
J Dermatolog Treat. 2004 Apr;15(2):98-103. doi: 10.1080/09546630410023322.
9
Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.采用银屑病面积和严重程度指数评分(改善75%或更高),对口服补骨脂素加紫外线A治疗斑块型银屑病的疗效进行随机、双盲、安慰剂对照评估,为期12周。
J Am Acad Dermatol. 2009 Nov;61(5):793-8. doi: 10.1016/j.jaad.2009.04.053. Epub 2009 Sep 18.
10
Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.银屑病治疗与心血管危险因素:一项为期 12 周的随访研究。
Am J Clin Dermatol. 2010 Dec 1;11(6):423-32. doi: 10.2165/11319310-000000000-00000.